Departamento de Gastroenterologia - FM/MGT

A missão do Departamento de Gastroenterologia da Faculdade de Medicina da Universidade de São Paulo (FMUSP) é gerar, transmitir e difundir conhecimentos, aplicá-los na formação de profissionais da área de saúde e na prestação de serviços e orientação à comunidade, visando a prevenção e o tratamento das doenças do aparelho digestivo.

Desenvolve atividades relacionadas à graduação, pesquisa e extensão nas áreas de hepatites virais, cirrose e suas complicações, doenças autoimunes do fígado, hipertensão portal, carcinoma hepatocelular, câncer gastrointestinal, doença inflamatória do intestino,doença do refluxo gastroesofágico, obesidade e síndrome metabólica, cirurgia laparoscópica avançada, transplante de fígado e transplante de pâncreas.

Site oficial: http://www2.fm.usp.br/gastro/

Browse

Recent Submissions

  1. Non-Alcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: Immunohistochemical Assessment of Markers of Cancer Cell Metabolism

    PATHOBIOLOGY, v.89, n.3, p.157-165, 2022

    Introduction: Hepatocellular carcinoma (HCC) has been associated to non-alcoholic fatty liver disease (NAFLD). We sought to investigate the immunoexpression of several glycolytic metabolism-associated markers in patients with HCC associated to NAFLD and associate these factors to their clinical-p...

  2. Liver resection for hepatocellular carcinoma beyond the BCLC: are multinodular disease, portal hypertension, and portal system invasion real contraindications?

    JOURNAL OF GASTROINTESTINAL ONCOLOGY, v.13, n.6, p.3123-3134, 2022

    Background: Barcelona Clinic Liver Cancer (BCLC) is a recognized guideline to standardize treatment allocation for hepatocellular carcinoma (HCC); however, many centers criticize its restrictive liver resection recommendations and have published good results after more liberal hepatectomy indicat...

  3. Lung microbiome and origins of the respiratory diseases

    CURRENT RESEARCH IN IMMUNOLOGY, v.4, article ID 100065, p, 2023

    The studies on the composition of the human microbiomes in healthy individuals, its variability in the course of inflammation, infection, antibiotic therapy, diets and different pathological conditions have revealed their intra and inter-kingdom relationships. The lung microbiome comprises of maj...

  4. Potential Beneficial Effect of Rifaximin in the Prevention of Hepatocellular Carcinoma through the Modulation of the Microbiota in an Experimental Model of Non-alcoholic Fatty Liver Disease

    ACTA GASTROENTEROLOGICA LATINOAMERICANA, v.53, n.3, p.265-282, 2023

    Summary Aim. To evaluate the effects of rifaximin through microbiota modulation in a model of hepatocellular carcinoma secondary to non-alcoholic fatty liver disease. Methods. Three groups of 8 adult male Sprague-Dawley rats each were divided as follows: the HCC group: rats fed a high-fat and cho...

  5. PRIVATE INSURANCE ACCESS IS ASSOCIATED WITH HIGHER LIVER TRANSPLANT LISTING AND TRANSPLANT ACCESS AND LOWER MORTALITY COMPARED TO NATIONAL INSURANCES IN A LARGE MULTINATIONAL COHORT OF INPATIENTS WITH CIRRHOSIS

    HEPATOLOGY, v.78, suppl.1, p.S1292-S1296, 2023

  6. PATIENTS WITH ACUTE ON CHRONIC LIVER FAILURE ARE AT HIGHER RISK OF PROCEDURAL-RELATED BLEEDING

    HEPATOLOGY, v.78, suppl.1, p.S193-S194, 2023

  7. SYSTEMATIC REVIEW AND META-ANALYSIS OF COLON CAPSULE ENDOSCOPY ACCURACY FOR COLORECTAL CANCER SCREENING. AN ALTERNATIVE DURING THE COVID ERA?

    GASTROINTESTINAL ENDOSCOPY, v.93, n.6, suppl.S, p.AB100-AB100, 2021

  8. REGIONAL DIFFERENCES IN ACUTE KIDNEY INJURY PREVALENCE, CLINICAL CHARACTERISTICS AND PATIENT OUTCOMES IN A MULTI-NATIONAL CONSORTIUM OF INPATIENTS WITH CIRRHOSIS

    HEPATOLOGY, v.78, suppl.1, p.S1355-S1359, 2023

  9. GLOBAL PREVALENCE OF INFECTIONS AND IMPACT OF REGIONAL VARIATIONS ON OUTCOMES: MULTI-NATIONAL CONSORTIUM OF CIRRHOSIS STUDY

    HEPATOLOGY, v.78, suppl.1, p.S172-S175, 2023

  10. ALCOHOL-RELATED ETIOLOGY IS AN INDEPENDENT PREDICTOR OF INPATIENT MORTALITY IN PATIENTS WITH CIRRHOSIS IN A PROSPECTIVE GLOBAL CONSORTIUM

    HEPATOLOGY, v.78, suppl.1, p.S1576-S1579, 2023